Cited by 1,251Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Open access

O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., for the Hypertrophic Cardiomyopathy Outcomes Investigators·2014·European Heart Journal

DOI 10.1093/eurheartj/eht439

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht439

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citation
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

Show all 50 references

Research works printed but not linked: 1

2012, Circulation: Arrhythmia and Electrophysiology, 6, 443

Sorted by citations

Items 101–200 of 999

Deep‐learning artificial intelligence analysis of clinical variables predicts mortality in COVID‐19 patients
Zhu, J., Ge, P., Jiang, C., Zhang, Y., Li, X., Zhao, Z., Zhang, L., & Duong, T. Q. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12205 · Cited by 96
Hypertrophic Cardiomyopathy: A Review
Houston, B. A., & Stevens, G. R. (2014) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s15717 · Cited by 101
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.001 · Cited by 92
Hypertrophic cardiomyopathy: a practical approach to guideline directed management
Ommen, S. R., & Semsarian, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01205-8 · Cited by 92
Arrhythmias as Presentation of Genetic Cardiomyopathy
Laws, J. L., Lancaster, M. C., Shoemaker, M. B., Stevenson, W. G., Hung, R. R., Wells, Q. S., Brinkley, D. M., Hughes, S. G., Anderson, K. C., Roden, D. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.319835 · Cited by 92
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Maron, B. J., Rowin, E. J., & Maron, M. S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.01.019 · Cited by 89
Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients
Gómez, J., Lorca, R., Reguero, J. R., Morı́s, C., Martı́n, M., Tranche, S., Alonso, B., Iglesias, S., Álvarez, V., Molina, B. D., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001584 · Cited by 89
Review and evaluation of performance measures for survival prediction models in external validation settings
Rahman, M. S., Ambler, G., Choodari‐Oskooei, B., & Omar, R. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0336-2 · Cited by 89
Self-citation
Association Between Atrial Fibrillation and Sudden Cardiac Death
Waldmann, V., Jouven, X., Narayanan, K., Piot, O., Chugh, S. S., Albert, C. M., & Marijon, É. (2020) · Circulation Research · doi:10.1161/circresaha.120.316756 · Cited by 91
Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
Lyon, A., Ariga, R., Mincholé, A., Mahmod, M., Ormondroyd, E., Laguna, P., de Freitas, N., Neubauer, S., Watkins, H. C., & Rodríguez, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00213 · Cited by 85
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Casas, G., Freire, J. L., Oristrell, G., Gutiérrez, L., Andreini, D., Borregán, M., Larrañaga-Moreira, J. M., López‐Sainz, Á., Codina‐Solà, M., Teixidó‐Turà, G., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.016 · Cited by 84
Self-citation
Risk stratification of sudden cardiac death: a review
Tfelt‐Hansen, J., Garcia, R., Albert, C. M., Merino, J. L., Krahn, A. D., Marijon, É., Basso, C., Wilde, A. A. M., & Haugaa, K. H. (2023) · EP Europace · doi:10.1093/europace/euad203 · Cited by 84
Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment
Makavos, G., Κairis, C., Tselegkidi, M.-E., Karamitsos, T. D., Rigopoulos, A. G., Noutsias, M., & Ikonomidis, I. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09775-4 · Cited by 86
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
Jordà, P., Bosman, L. P., Gasperetti, A., Mazzanti, A., Gourraud, J., Davies, B., Frederiksen, T. C., Weidmann, Z. M., Marco, A. D., Roberts, J. D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac289 · Cited by 86
The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data
Wood, A. M., Royston, P., & White, I. R. (2015) · Biometrical Journal · doi:10.1002/bimj.201400004 · Cited by 78
Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy
Hinojar, R., Zamorano, J. L., Fernández-Méndez, M. Á., Esteban, A., Martín, M. P., González-Gómez, A., Carbonell, A., Rincon, L. M., Nácher, J. J. J., & Fernández‐Golfín, C. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01534-8 · Cited by 79
Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines
Wang, J., Yang, S., Ma, X., Zhao, K., Yang, K., Yu, S., Yin, G., Dong, Z., Song, Y., Cui, C., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad581 · Cited by 77
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study
Balaji, S., DiLorenzo, M. P., Fish, F. A., Etheridge, S. P., Aziz, P. F., Russell, M. W. W., Tisma‐Dupanovic, S., Pflaumer, A., Sreeram, N., Kubuš, P., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.040 · Cited by 76
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 87
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, M. S., Chan, R. H. M., Hausvater, A., Wang, W., Rastegar, H., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.048 · Cited by 76
Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
Viswanathan, S. K., Sanders, H. K., McNamara, J. W., Jagadeesan, A., Jahangir, A., Tajik, A. J., & Sadayappan, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187948 · Cited by 76
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy
Smole, T., Žunkovič, B., Pičulin, M., Kokalj, E., Robnik‐Šikonja, M., Kukar, M., Fotiadis, D. I., Pezoulas, V. C., Tachos, N. S., Barlocco, F., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104648 · Cited by 77
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
Mazzarotto, F., Olivotto, I., Boschi, B., Girolami, F., Poggesi, C., Barton, P. J. R., & Walsh, R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015473 · Cited by 63
International Consensus on Differential Diagnosis and Management of Patients With Danon Disease
Hong, K. N., Eshraghian, E. A., Arad, M., Argirò, A., Brambatti, M., Bui, Q. M., Caspi, O., de Frutos, F., Greenberg, B., Ho, C. Y., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.014 · Cited by 73
Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR
Avanesov, M., Münch, J., Weinrich, J. M., Well, L., Säring, D., Stehning, C., Tahir, E., Bohnen, S., Radunski, U. K., Muellerleile, K., et al. (2017) · European Radiology · doi:10.1007/s00330-017-4869-x · Cited by 73
Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy
on behalf of Italian Chapter of, I. S. C. U., Parato, V. M., Antoncecchi, V., Sozzi, F. B., Marazìa, S., Zito, A., Maiello, M. R., & Palmiero, P. (2015) · Cardiovascular Ultrasound · doi:10.1186/s12947-016-0072-5 · Cited by 72
Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model)
Bhattacharya, M., Lu, D., Kudchadkar, S. M., Greenland, G. V., Lingamaneni, P., Corona‐Villalobos, C. P., Guan, Y., Marine, J. E., Olgin, J. E., Zimmerman, S. L., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.022 · Cited by 70
Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy
Liu, H., Pozios, I., Haileselassie, B., Nowbar, A. N., Sorensen, L. L., Phillip, S., Lu, D., Ventoulis, I., Luo, H., Abraham, M. R., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.039 · Cited by 71
Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients
Debonnaire, P., Thijssen, J., Leong, D. P., Joyce, E., Katsanos, S., Hoogslag, G. E., Schalij, M. J., Atsma, D. E., Bax, J. J., Delgado, V., et al. (2014) · International journal of cardiac imaging · doi:10.1007/s10554-014-0378-z · Cited by 70
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
García-Giustiniani, D. A., Arad, M., Ortiz-Genga, M., Villa, R. B., Fernández, X., Rodrı́guez, I., Mazzanti, A., Veira, E., Maneiro, E., Rebolo-Bardanca, P., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307205 · Cited by 70
Self-citation
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy
Nauffal, V., Marstrand, P., Han, L., Parikh, V. N., Helms, A. S., Ingles, J., Jacoby, D. L., Lakdawala, N. K., Kapur, S., Michels, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab598 · Cited by 69
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
Norrish, G., Chen, Q., Field, E., Cervi, E., Khraiche, D., Klaassen, S., Ojala, T. H., Sinagra, G., Yamazawa, H., Marrone, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab181 · Cited by 69
Self-citation
New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic
Narayan, S. M., Wang, P. J., & Daubert, J. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.083 · Cited by 69
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology
Elliot, P. M., Charron, P., Gimeno, J. R., Tavazzi, L., Tendera, M., Konté, M., Laroche, C., & Maggioni, A. P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv497 · Cited by 66
Self-citation
Machine Learning-Based Surgical Planning for Neurosurgery: Artificial Intelligent Approaches to the Cranium
Dündar, T. T., Yurtsever, İ., Pehlivanoğlu, M. K., Yıldız, U., Eker, A. G., Demir, M. A., Mutluer, A. S., Tektaş, R., Kazan, M. S., Kitiş, S., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.863633 · Cited by 71
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy
Magrì, D., Limongelli, G., Re, F., Agostoni, P., Zachara, E., Correale, M., Mastromarino, V., Santolamazza, C., Casenghi, M., Pacileo, G., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308453 · Cited by 66
Self-citation
Machine learning in sudden cardiac death risk prediction: a systematic review
Barker, J., Li, X., Khavandi, S., Koeckerling, D., Mavilakandy, A. K., Pepper, C., Bountziouka, V., Chen, L., Kotb, A. I., Antoun, I., et al. (2022) · EP Europace · doi:10.1093/europace/euac135 · Cited by 64
Heart Failure Progression in Hypertrophic Cardiomyopathy – Possible Insights From Cardiopulmonary Exercise Testing –
Magrì, D., Re, F., Limongelli, G., Agostoni, P., Zachara, E., Correale, M., Mastromarino, V., Santolamazza, C., Casenghi, M., Pacileo, G., et al. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0432 · Cited by 65
Self-citation
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy
Masri, A., Cardoso, R. N., Abraham, T. P., Claggett, B. L., COATS, C. J., Hegde, S. M., Kulac, I. J., Lee, M. M. Y., Maron, M. S., Merkely, B. P., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.015 · Cited by 68
Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults
Ng, Y. S., Grady, J. P., Lax, N. Z., Bourke, J. P., Alston, C. L., Hardy, S. A., Falkous, G., Schaefer, A. M., Radunović, A., MOHIDDIN, S. A., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv306 · Cited by 64
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
Norrish, G., Ding, T., Field, E., McLEOD, K. A., Ilina, M. V., Stuart, G., Bhole, V., Uzun, O., Brown, E., Daubeney, P. E. F., et al. (2019) · EP Europace · doi:10.1093/europace/euz118 · Cited by 63
Self-citation
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy
Olivotto, I., Hellawell, J. L., Farzaneh‐Far, R., Blair, C. J., Coppini, R., MYERS, J. N., Belardinelli, L., & Maron, M. S. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002764 · Cited by 62
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management
Ali, A. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1556 · Cited by 62
QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy
Debonnaire, P., Katsanos, S., Joyce, E., van den Brink, O. W. V., Atsma, D. E., Schalij, M. J., Bax, J. J., Delgado, V., & Marsan, N. A. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12629 · Cited by 62
Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria
Desai, M. Y., Smedira, N. G., Dhillon, A. S., Masri, A., Wazni, O. M., Kanj, M., Sato, K., Thamilarasan, M., Popović, Z., & Lever, H. M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.150 · Cited by 59
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis
O’Mahony, C., Akhtar, M. M., Anastasiou, Z., Guttmann, O. P., Vriesendorp, P. A., Michels, M., Magrì, D., Autore, C., Fernández, A., Ochoa, J. P., et al. (2018) · Heart · doi:10.1136/heartjnl-2018-313700 · Cited by 59
Self-citation
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score
Todiere, G., Nugara, C., Gentile, G., Negri, F., Bianco, F., Falletta, C., Novo, G., Bella, G. D., Caterina, R. D., Zachara, E., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.023 · Cited by 59
Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study
Greulich, S., Seitz, A., Herter, D., Günther, F., Probst, S., Bekeredjian, R., Gawaz, M., Sechtem, U. P., & Mahrholdt, H. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa423 · Cited by 58
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
Mazzanti, A., Trancuccio, A., Kukavica, D., Pagan, E., Wang, M., Mohsin, M. J., Peterson, D. R., Bagnardi, V., Zaręba, W., & Priori, S. G. (2021) · EP Europace · doi:10.1093/europace/euab238 · Cited by 58
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.
Fahmy, A., Rowin, E., Jaafar, N., Chan, R., Rodriguez, J., Nakamori, S., Ngo, L., Pradella, S., Zocchi, C., Olivotto, I., et al. (2023) · JACC Cardiovascular Imaging · doi:10.1016/j.jcmg.2023.05.003 · Cited by 59
Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy
Ziółkowska, L., Turska‐Kmieć, A., Petryka, J., & Kawalec, W. (2015) · Pediatric Cardiology · doi:10.1007/s00246-015-1298-y · Cited by 58
Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry
Ciampi, Q., Olivotto, I., Gardini, C., Mori, F., Peteiro, J., Monserrat, L., Fernández, X., Cortigiani, L., Rigo, F., Lopes, L. R., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.044 · Cited by 57
Self-citation
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps
Zhu, J., Hou, W., Xu, Y., Ji, F., Wang, G., Chen, C., Lin, C., Lin, X., Li, J., Zhuo, C., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112598 · Cited by 56
Estimation of required sample size for external validation of risk models for binary outcomes
Pavlou, M., Chen, Q., Omar, R., Seaman, S. R., Steyerberg, E. W., White, I. R., & Ambler, G. (2021) · Statistical Methods in Medical Research · doi:10.1177/09622802211007522 · Cited by 58
Self-citation
Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy
Lee, H. J., Kim, H., Lee, S., Kim, J., Park, J. B., Hwang, I. C., Choi, Y. J., Lee, S., Chang, S., Lee, W., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab187 · Cited by 56
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy
Kłopotowski, M. M., Kukuła, K., Małek, Ł. A., Śpiewak, M., Polańska-Skrzypczyk, M., Jamiołkowski, J., Dąbrowski, M., Baranowski, R., Klisiewicz, A., Kuśmierczyk, M., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.07.020 · Cited by 55
Strain Imaging Echocardiography: What Imaging Cardiologists Should Know
López‐Candales, A., & Hernández-Suárez, D. F. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666161028122649 · Cited by 55
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)
Vehmeijer, J. T., Koyak, Z., Leerink, J. M., Zwinderman, A. H., Harris, L., Peinado, R., Oechslin, E. N., Robbers‐Visser, D., Groenink, M., Boekholdt, S. M., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.01.009 · Cited by 54
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy
Maurizi, N., Olivotto, I., Nordkamp, L. R. A. O., Baldini, K., Fumagalli, C., Brouwer, T. F., Knops, R. E., & Cecchi, F. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.007 · Cited by 54
High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device
Wilke, I., Witzel, K., Münch, J., Pecha, S., Blankenberg, S., Reichenspurner, H. C., Willems, S., Patten, M., & Aydın, A. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12982 · Cited by 54
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
Bytyçi, I., Nistri, S., Mörner, S., & Henein, M. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103062 · Cited by 54
Hypertrophic cardiomyopathy
Antunes, M. D. O., & Scudeler, T. L. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100503 · Cited by 53
Diagnosis and management of hypertrophic cardiomyopathy
Pantazis, A. A., Vischer, A. S., Perez-Tome, M. C., & Castelletti, S. (2015) · Echo Research and Practice · doi:10.1530/erp-15-0007 · Cited by 52
Research Opportunities in the Treatment of Mitral Valve Prolapse
Delling, F. N., Noseworthy, P. A., Adams, D. H., Basso, C., Borger, M. A., Bouatia‐Naji, N., Elmariah, S., Evans, F., Gerstenfeld, E. P., Hung, J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.044 · Cited by 53
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis
Shiwani, H., Davies, R. H., Topriceanu, C., Ditaranto, R., OWENS, A. T., Raman, B., Augusto, J. B., Hughes, R. K., Torlasco, C., Dowsing, B., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.082 · Cited by 52
Self-citation
Research priorities in sarcomeric cardiomyopathies
van der Velden, J., Ho, C. Y., Tardiff, J. C., Olivotto, I., Knollmann, B. C., & Carrier, L. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv019 · Cited by 53
Left ventricular outflow tract obstruction in ICU patients
Slama, M., Tribouilloy, C. M., & Maizel, J. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000304 · Cited by 52
Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning
Captur, G., Heywood, W., COATS, C. J., Rosmini, S., Patel, V., Lopes, L. R., Collis, R., Patel, N., Syrris, P., Bassett, P., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001586 · Cited by 56
Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy
O’Hara, R. P., Binka, E., Prakosa, A., Zimmerman, S. L., Cartoski, M. J., Abraham, M. R., Lu, D.-Y., Boyle, P. M., & Trayanova, N. A. (2022) · eLife · doi:10.7554/elife.73325 · Cited by 51
Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
Soler, R., Méndez, C., Rodrı́guez, E., Villa, R. B., Ochoa, J. P., & Monserrat, L. (2018) · Insights into Imaging · doi:10.1007/s13244-018-0656-8 · Cited by 51
Self-citation
A Systematic Review of Phenotypic Features Associated With Cardiac Troponin I Mutations in Hereditary Cardiomyopathies
Mogensen, J., Hey, T. M., & Lambrecht, S. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.015 · Cited by 51
Management of Ventricular Arrhythmias Worldwide
Könemann, H., Ellermann, C., Zeppenfeld, K., & Eckardt, L. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.12.008 · Cited by 60
Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians
Choi, Y., Kim, H., Lee, S., Park, J., Moon, I., Park, J., Kim, Y.-J., Sohn, D., & Ommen, S. R. (2019) · Heart · doi:10.1136/heartjnl-2019-315160 · Cited by 50
Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
Kumar, S., Ness, G. V., Bender, A. B., Yadava, M., Minnier, J., Ravi, S., McGrath, L. B., Song, H. K., & Heitner, S. B. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.01.022 · Cited by 49
Genetics and Genomics of Single-Gene Cardiovascular Diseases
Marian, A. J., van Rooij, E., & Roberts, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.968 · Cited by 48
Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis
Kamp, N., Chery, G. S., Kosinski, A. S., Desai, M. Y., Wazni, O. M., Sanders, G. D., Patel, M. R., Lópes, R. D., Morin, D. P., & Al‐Khatib, S. M. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.11.001 · Cited by 48
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study
Negri, F., Muser, D., Driussi, M., Sanna, G. D., Masè, M., Cittar, M., Poli, S., Bellis, A. D., Fabris, E., Puppato, M., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.148 · Cited by 48
Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy
Leong, K. M. W., Chow, J., Ng, F. S., Falaschetti, E., Qureshi, N. A., Koa‐Wing, M., Linton, N. W. F., Whinnett, Z. I., Lefroy, D. C., Davies, D. W., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.10.027 · Cited by 48
Deep learning prediction of mild cognitive impairment conversion to Alzheimer’s disease at 3 years after diagnosis using longitudinal and whole-brain 3D MRI
Ocasio, E., & Duong, T. Q. (2021) · PeerJ Computer Science · doi:10.7717/peerj-cs.560 · Cited by 51
Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy
Kang, K., Janardhan, A. H., Jung, K. T., Lee, H. S., Lee, M., & Hwang, H. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.002 · Cited by 47
A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life
Calore, C., Bortoli, M. D., Romualdi, C., Lorenzon, A., Angelini, A., Basso, C., Thiene, G., Iliceto, S., Rampazzo, A., & Melacini, P. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102923 · Cited by 47
The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results
Cardim, N. M., Brito, D. A., Lopes, L. R., Freitas, A., Araújo, C., Belo, A., Gonçalves, L. M. M., Mimoso, J., Olivotto, I., Elliot, P. M., et al. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.08.005 · Cited by 47
Variable and Limited Predictive Value of the European Society of Cardiology Hypertrophic Cardiomyopathy Sudden-Death Risk Model: A Meta-analysis
Wang, J., Zhang, Z., Li, Y., Xu, Y., Wan, K., & Chen, Y. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.05.004 · Cited by 46
Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification
Tower-Rader, A. F., Kramer, C. M., Neubauer, S., Nagueh, S. F., & Desai, M. Y. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.009026 · Cited by 47
Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
Sammani, A., Kayvanpour, E., Bosman, L. P., Sedaghat‐Hamedani, F., Proctor, T., Gi, W., Broezel, A., Jensen, K., Katus, H. A., Riele, A. S. J. M. T., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12689 · Cited by 47
Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies
Marian, A. J., Asatryan, B., & Wehrens, X. H. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa116 · Cited by 49
2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
Габрусенко, С. А., Gudkova, A. Y., Koziolova, N. A., Alexandrova, S. А., Berseneva, M., Гордеев, М. Л., Sl, D., Zaklyazminskaya, E. V., Irtyuga, O. B., Kaplunova, V. Y., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4541 · Cited by 56
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
Hong, Y., SU, W. W., & Li, X. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000939 · Cited by 46
Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy
Lai, C., Yin, M., Kholmovski, E. G., Popescu, D. M., Lu, D., Scherer, E., Binka, E., Zimmerman, S. L., Chrispin, J., Hays, A. G., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00679-1 · Cited by 50
Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation
Liebregts, M., Faber, L., Jensen, M. K., Vriesendorp, P. A., Hansen, P. R., Seggewiß, H., Horstkotte, D., Adlová, R., Michels, M., Bundgaard, H., et al. (2017) · EP Europace · doi:10.1093/europace/eux251 · Cited by 46
Machine learning for predicting cardiac events: what does the future hold?
Patel, B. D., & Sengupta, P. P. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1732208 · Cited by 48
Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
Siontis, K. C., Ommen, S. R., & Geske, J. B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.014448 · Cited by 46
Fractal Analysis: Prognostic Value of Left Ventricular Trabecular Complexity Cardiovascular MRI in Participants with Hypertrophic Cardiomyopathy
Wang, J., Li, Y., Yang, F., Bravo, L., Wan, K., Xu, Y., Cheng, W., Sun, J., Zhu, Y., Zhu, T., et al. (2020) · Radiology · doi:10.1148/radiol.2020202261 · Cited by 44
Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease
Orsborne, C., Bradley, J., Bonnett, L. J., Pleva, L. A., Naish, J. H., Clark, D. G., Abidin, N., Woolfson, P. I., Nucifora, G., Schmitt, M., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.022 · Cited by 43
The role of multi-modality imaging for the assessment of left atrium and left atrial appendage: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
Sade, L. E., Faletra, F. F., Pontone, G., Gerber, B. L., Muraru, D., Edvardsen, T., Cosyns, B., Popescu, B. A., Klein, A. L., Marwick, T. H., et al. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf014 · Cited by 45
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy
Rosmini, S., Biagini, E., O’Mahony, C., Bulluck, H., Ruozi, N., Lopes, L. R., Guttmann, O. P., Réant, P., Quarta, C. C., Pantazis, A. A., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-310138 · Cited by 43
Self-citation
Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
Smith, J. G., Felix, J. F., Morrison, A. C., Kalogeropoulos, A. P., Trompet, S., Wilk, J. B., Gidlöf, O., Wang, X., Morley, M. P., Mendelson, M., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006034 · Cited by 42
Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy
Srinivasan, N. T., Patel, K. H. K., Qamar, K., Taylor, A., Bacà, M., Providencia, R. A., Tome, M., Elliot, P. M., & Lambiase, P. D. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.004801 · Cited by 43

Authors: O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
Affiliations: University College London (GB)
National and Kapodistrian University of Athens (GR)
University of Bologna (IT)
Hospital Universitario Virgen de la Arrixaca (ES)
University of Campania "Luigi Vanvitelli" (IT)
University College Hospital at Westmoreland Street (GB)
ORCID: Pavlou, M.
Monserrat, L.
Rapezzi, C.
Biagini, E.
Gimeno, J. R.
Limongelli, G.
McKenna, W. J.
Omar, R. Z.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2013-10-14
Volume: 35
Issue: 30
Pages: 2010-2020
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/eht439
OpenAlex: W2119361626
Cited by: 1,251
References: 50
Citations by year: 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
FWCI: 39.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Hispana (submittedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders: National Institute for Health and Care Research (NF-SI-0509-10230)
Università di Bologna
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
MeSH terms: Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks